These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2080757

  • 1. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses.
    Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K.
    Agents Actions Suppl; 1990; 31():251-4. PubMed ID: 2080757
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs.
    Sakuma Y, Tsunoda H, Shirato M, Katayama S, Yamatsu I, Katayama K.
    Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K.
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice.
    Sakuma Y, Muramoto K, Harada K, Katayama S, Tsunoda H, Katayama K.
    Prostaglandins; 1991 Dec; 42(6):541-55. PubMed ID: 1801063
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 6. Effects of a novel PAF antagonist, E6123, on passive anaphylaxis.
    Sakuma Y, Tsunoda H, Katayama S, Harada K, Obaishi H, Shirato M, Yamada K, Miyazawa S, Okano K, Machida Y.
    Agents Actions Suppl; 1990 Oct; 31():255-8. PubMed ID: 2080758
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 8. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M.
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S, Mikashima H, Muramoto Y, Terasawa M, Setoguchi M, Tahara T.
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of PAF in postallergic propranolol-induced bronchoconstriction in guinea-pigs.
    Fujimura M, Tsujiura M, Songür N, Myou S, Matsuda T.
    Eur Respir J; 1996 Oct; 9(10):2064-9. PubMed ID: 8902468
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE.
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [Abstract] [Full Text] [Related]

  • 15. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
    Heuer HO.
    J Lipid Mediat; 1991 Aug; 4(1):39-44. PubMed ID: 1893086
    [Abstract] [Full Text] [Related]

  • 16. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, Nishikawa K.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
    Parry MJ, Alabaster VA, Cheeseman HE, Cooper K, deSouza RN, Keir RF.
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):251-68. PubMed ID: 7812676
    [Abstract] [Full Text] [Related]

  • 19. Development of radioimmunoassay for the novel platelet activating factor receptor antagonist, E6123, and its application to pharmacokinetics in laboratory animals.
    Kusano K, Tadano K, Tanaka S, Kagei Y, Ueda M, Miyazawa S, Abe Y, Ida S, Yuzuriha T.
    Biol Pharm Bull; 1994 Feb; 17(2):334-9. PubMed ID: 8205134
    [Abstract] [Full Text] [Related]

  • 20. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW, Dent G, Rogers DF, Aursudkij B, Chung KF, Barnes PJ.
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.